Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)

Roche plans to modernize its capital structure, seeking shareholder approval at the 2026 Annual General Meeting. Non-voting equity securities ("Genussscheine") will be exchanged for participation certificates, each with a nominal value of CHF 0.001. The nominal value of bearer shares will decrease from CHF 1 to CHF 0.001, providing shareholders CHF 0.999 per share. This exchange is aligned with revised Swiss corporate law and maintains economic equivalence between the new certificates and the shares. Participation certificates will be listed on the SIX Swiss Exchange, mirroring the dividend and liquidation rights of bearer shares. Roche will discontinue printed dividend vouchers, transitioning to intermediated securities for efficiency. Home custodians are urged to convert existing certificates and vouchers into intermediated securities promptly to avoid lost dividends. Roche will no longer issue printed certificates for any equity securities in the future. Detailed information regarding the proposals will be provided in the shareholder invitation to the 2026 AGM. Roche, founded in 1896, is committed to developing innovative medicines and diagnostics.